IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.2600
+0.0037 (1.44%)
At close: Jul 17, 2026, 4:00 PM EDT
0.2600
0.00 (0.00%)
After-hours: Jul 17, 2026, 4:10 PM EDT
IGC Pharma Employees
IGC Pharma had 70 employees as of March 31, 2025. The number of employees increased by 3 or 4.48% compared to the previous year.
Employees
70
Change (1Y)
3
Growth (1Y)
4.48%
Revenue / Employee
$15,800
Profits / Employee
-$92,086
Market Cap
26.02M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2025 | 70 | 3 | 4.48% | 70 | 0 |
| Mar 31, 2024 | 67 | 6 | 9.84% | 67 | 0 |
| Mar 31, 2023 | 61 | 9 | 17.31% | 61 | 0 |
| Mar 31, 2022 | 52 | 2 | 4.00% | 52 | 0 |
| Mar 31, 2021 | 50 | 0 | - | 50 | 0 |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evaxion | 46 |
| Kyntra Bio | 34 |
| Plus Therapeutics | 28 |
| Actinium Pharmaceuticals | 25 |
| NeuroSense Therapeutics | 17 |
| Serina Therapeutics | 16 |
| Barinthus Biotherapeutics | 14 |
| Tvardi Therapeutics | 12 |
IGC News
- 4 days ago - IGC Pharma Slides: Investor presentation - Filings
- 8 days ago - IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Time by 90% in Representative Workflow - Accesswire
- 10 days ago - IGC Pharma CEO, principal financial officer purchase over $1.15M of stock - TheFly
- 10 days ago - IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company - Accesswire
- 24 days ago - IGC Pharma announced beta version of Agentic Harmonization Assistant - TheFly
- 24 days ago - IGC Pharma's AHA Agentic AI Platform Reduces Alzheimer's Data Harmonization Time by 90% in Representative Workflow - Accesswire
- 5 weeks ago - IGC Pharma reaches 146-patient enrollment target for Phase 2 Calma trial - TheFly
- 5 weeks ago - IGC Pharma Reaches Previously Disclosed 146-Patient Enrollment Target in Phase 2 CALMA Trial, Advancing Toward Topline Analysis - Accesswire